Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma

Stan van Keulen, Nynke S. van den Berg, Naoki Nishio, Andrew Birkeland, Quan Zhou, Guolan Lu, Han-Wei Wang, Lyle Middendorf, Tymour Forouzanfar, Brock A. Martin, A. Dimitrios Colevas, Eben L. Rosenthal

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: Surgical resection remains the primary treatment for the majority of solid tumors. Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in 15–30% of head and neck cancer patients. Obtaining negative margins requires immediate, intraoperative feedback of margin status. To this end, we propose optical specimen mapping of resected tumor specimens immediately after removal. Materials and methods: A first-in-human pilot study was performed in patients (n = 8) after infusion of fluorescently labeled antibody, panitumumab-IRDye800 to allow surgical mapping of the tumor specimen. Patients underwent standard of care surgical resection for head and neck squamous cell carcinoma (HNSCC). Optical specimen mapping was performed on the primary tumor specimen and correlated with pathological findings after tissue processing. Results: Optical mapping of the specimen had a 95% sensitivity and 89% specificity to detect cancer within 5 mm (n = 160) of the cut surface. To detect tumor within 2 mm of the specimen surface, the sensitivity of optical specimen mapping was 100%. The maximal observed penetration depth of panitumumab-IRDye800 through human tissue in our study was 6.3 mm. Conclusion: Optical specimen mapping is a highly sensitive and specific method for evaluation of margins within <5 mm of the tumor mass in HNSCC specimens. This technology has potentially broad applications for ensuring adequate tumor resection and negative margins in head and neck cancers.
LanguageEnglish
Pages58-65
JournalOral Oncology
Volume88
DOIs
StatePublished - 2019

Cite this

van Keulen, S., van den Berg, N. S., Nishio, N., Birkeland, A., Zhou, Q., Lu, G., ... Rosenthal, E. L. (2019). Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncology, 88, 58-65. DOI: 10.1016/j.oraloncology.2018.11.012
van Keulen, Stan ; van den Berg, Nynke S. ; Nishio, Naoki ; Birkeland, Andrew ; Zhou, Quan ; Lu, Guolan ; Wang, Han-Wei ; Middendorf, Lyle ; Forouzanfar, Tymour ; Martin, Brock A. ; Colevas, A. Dimitrios ; Rosenthal, Eben L./ Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. In: Oral Oncology. 2019 ; Vol. 88. pp. 58-65
@article{3da46a84319e4d0c8541aafbc241c144,
title = "Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma",
abstract = "Objective: Surgical resection remains the primary treatment for the majority of solid tumors. Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in 15–30{\%} of head and neck cancer patients. Obtaining negative margins requires immediate, intraoperative feedback of margin status. To this end, we propose optical specimen mapping of resected tumor specimens immediately after removal. Materials and methods: A first-in-human pilot study was performed in patients (n = 8) after infusion of fluorescently labeled antibody, panitumumab-IRDye800 to allow surgical mapping of the tumor specimen. Patients underwent standard of care surgical resection for head and neck squamous cell carcinoma (HNSCC). Optical specimen mapping was performed on the primary tumor specimen and correlated with pathological findings after tissue processing. Results: Optical mapping of the specimen had a 95{\%} sensitivity and 89{\%} specificity to detect cancer within 5 mm (n = 160) of the cut surface. To detect tumor within 2 mm of the specimen surface, the sensitivity of optical specimen mapping was 100{\%}. The maximal observed penetration depth of panitumumab-IRDye800 through human tissue in our study was 6.3 mm. Conclusion: Optical specimen mapping is a highly sensitive and specific method for evaluation of margins within <5 mm of the tumor mass in HNSCC specimens. This technology has potentially broad applications for ensuring adequate tumor resection and negative margins in head and neck cancers.",
author = "{van Keulen}, Stan and {van den Berg}, {Nynke S.} and Naoki Nishio and Andrew Birkeland and Quan Zhou and Guolan Lu and Han-Wei Wang and Lyle Middendorf and Tymour Forouzanfar and Martin, {Brock A.} and Colevas, {A. Dimitrios} and Rosenthal, {Eben L.}",
year = "2019",
doi = "10.1016/j.oraloncology.2018.11.012",
language = "English",
volume = "88",
pages = "58--65",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

van Keulen, S, van den Berg, NS, Nishio, N, Birkeland, A, Zhou, Q, Lu, G, Wang, H-W, Middendorf, L, Forouzanfar, T, Martin, BA, Colevas, AD & Rosenthal, EL 2019, 'Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma' Oral Oncology, vol. 88, pp. 58-65. DOI: 10.1016/j.oraloncology.2018.11.012

Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. / van Keulen, Stan; van den Berg, Nynke S.; Nishio, Naoki; Birkeland, Andrew; Zhou, Quan; Lu, Guolan; Wang, Han-Wei; Middendorf, Lyle; Forouzanfar, Tymour; Martin, Brock A.; Colevas, A. Dimitrios; Rosenthal, Eben L.

In: Oral Oncology, Vol. 88, 2019, p. 58-65.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma

AU - van Keulen,Stan

AU - van den Berg,Nynke S.

AU - Nishio,Naoki

AU - Birkeland,Andrew

AU - Zhou,Quan

AU - Lu,Guolan

AU - Wang,Han-Wei

AU - Middendorf,Lyle

AU - Forouzanfar,Tymour

AU - Martin,Brock A.

AU - Colevas,A. Dimitrios

AU - Rosenthal,Eben L.

PY - 2019

Y1 - 2019

N2 - Objective: Surgical resection remains the primary treatment for the majority of solid tumors. Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in 15–30% of head and neck cancer patients. Obtaining negative margins requires immediate, intraoperative feedback of margin status. To this end, we propose optical specimen mapping of resected tumor specimens immediately after removal. Materials and methods: A first-in-human pilot study was performed in patients (n = 8) after infusion of fluorescently labeled antibody, panitumumab-IRDye800 to allow surgical mapping of the tumor specimen. Patients underwent standard of care surgical resection for head and neck squamous cell carcinoma (HNSCC). Optical specimen mapping was performed on the primary tumor specimen and correlated with pathological findings after tissue processing. Results: Optical mapping of the specimen had a 95% sensitivity and 89% specificity to detect cancer within 5 mm (n = 160) of the cut surface. To detect tumor within 2 mm of the specimen surface, the sensitivity of optical specimen mapping was 100%. The maximal observed penetration depth of panitumumab-IRDye800 through human tissue in our study was 6.3 mm. Conclusion: Optical specimen mapping is a highly sensitive and specific method for evaluation of margins within <5 mm of the tumor mass in HNSCC specimens. This technology has potentially broad applications for ensuring adequate tumor resection and negative margins in head and neck cancers.

AB - Objective: Surgical resection remains the primary treatment for the majority of solid tumors. Despite efforts to obtain wide margins, close or positive surgical margins (<5 mm) are found in 15–30% of head and neck cancer patients. Obtaining negative margins requires immediate, intraoperative feedback of margin status. To this end, we propose optical specimen mapping of resected tumor specimens immediately after removal. Materials and methods: A first-in-human pilot study was performed in patients (n = 8) after infusion of fluorescently labeled antibody, panitumumab-IRDye800 to allow surgical mapping of the tumor specimen. Patients underwent standard of care surgical resection for head and neck squamous cell carcinoma (HNSCC). Optical specimen mapping was performed on the primary tumor specimen and correlated with pathological findings after tissue processing. Results: Optical mapping of the specimen had a 95% sensitivity and 89% specificity to detect cancer within 5 mm (n = 160) of the cut surface. To detect tumor within 2 mm of the specimen surface, the sensitivity of optical specimen mapping was 100%. The maximal observed penetration depth of panitumumab-IRDye800 through human tissue in our study was 6.3 mm. Conclusion: Optical specimen mapping is a highly sensitive and specific method for evaluation of margins within <5 mm of the tumor mass in HNSCC specimens. This technology has potentially broad applications for ensuring adequate tumor resection and negative margins in head and neck cancers.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056748209&origin=inward

U2 - 10.1016/j.oraloncology.2018.11.012

DO - 10.1016/j.oraloncology.2018.11.012

M3 - Article

VL - 88

SP - 58

EP - 65

JO - Oral Oncology

T2 - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

ER -

van Keulen S, van den Berg NS, Nishio N, Birkeland A, Zhou Q, Lu G et al. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncology. 2019;88:58-65. Available from, DOI: 10.1016/j.oraloncology.2018.11.012